This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked RAB32 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-RAB32 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~25 kDa | |
| Gel | 12–15% (standard starting point) | |
| Positive control | Adipose tissue (IHC candidate; verify WB) +4 more | |
| Negative control | Caudate (IHC candidate; verify WB) |
| PTM | Phosphorylated + Acetylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The A04645 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | Target-positive lysate and matched negative control (standard starting point) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Short semi-dry transfer; verify retention (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A04645; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
RAB32 is predicted at about 25 kDa; phosphorylation and membrane anchoring are documented, but their effects on band migration are not demonstrated.
| Band near 25 kDa | Consistent with the predicted RAB32 mass; confirm identity with appropriate controls |
| Weak band in a soluble fraction | Consistent with RAB32 association with mitochondrial and vesicle membranes |
| Band enriched in a membrane fraction | Consistent with RAB32 membrane localization and lipid anchoring |
| Additional nearby band | Could reflect a modified state such as phosphorylation at Ser71; identity requires confirmation |
| UniProt predicted mass | Places the expected RAB32 band near 25 kDa |
| N-acetylalanine at residue 2 | Is documented, but no visible size change is established |
| Phosphoserine at residue 71 | May affect migration, but no band shift is established |
| Membrane lipid anchor | Is documented, but its effect on apparent band size is not established |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Membrane-associated RAB32 may be poorly recovered | Check membrane fractions and extraction conditions |
| Band higher than expected | The supplied features do not establish the cause of a higher band | Confirm identity by RAB32 depletion and compare sample preparation conditions |
| Band lower than expected | The supplied features do not establish a cleaved RAB32 product | Confirm identity by RAB32 depletion and check sample integrity |
| Multiple bands | Phosphorylation at Ser71 is documented, but distinct bands are not established | Compare phosphatase-treated samples and use RAB32 depletion to identify specific bands |
| Weak or no signal | Membrane localization may limit recovery in the tested fraction | Check a membrane-enriched fraction and verify transfer |
| Fragments below expected size | Sample degradation is possible; no physiological cleavage is listed | Repeat with protease protection and confirm fragments by RAB32 depletion |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | High | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | High | Protein (IHC) | HPA → |
| Cerebral cortex | endothelial cells | High | Protein (IHC) | HPA → |
| Colon | endothelial cells | High | Protein (IHC) | HPA → |
| Liver | cholangiocytes | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Caudate | glial cells | Not detected | Protein (IHC) | HPA → |
| Cerebellum | cells in granular layer | Not detected | Protein (IHC) | HPA → |
| Cervix | glandular cells | Not detected | Protein (IHC) | HPA → |
| Pancreas | exocrine glandular cells | Not detected | Protein (IHC) | HPA → |
| Spleen | cells in red pulp | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for RAB32, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
A04645 is listed for RAB32 Western blotting with Human and Mouse reactivity. Its WB image uses SH-SY5Y cell lysate, with primary antibody diluted 1:1000 and incubated overnight at 4°C. The supplied evidence shows one tested sample context.
Which to pick: A04645 is the only listed option. Its WB image documents SH-SY5Y lysate under the stated conditions; check that this sample context and the listed Human or Mouse reactivity fit your experiment.